Empagliflozin in the Treatment of Heart Failure with Reduced Ejection Fraction in Addition to Background Therapies and Therapeutic Combinations (emperor-reduced): A Post-hoc Analysis of a Randomised, Double-blind Trial

Verma, Subodh, Dhingra, Nitish K, Butler, Javed, Anker, Stefan D, Ferreira, Joao Pedro, Filippatos, Gerasimos, Januzzi, James L, Lam, Carolyn S P, Sattar, Naveed, Peil, Barbara, Nordaby, Matias, Brueckmann, Martina, Pocock, Stuart J, Zannad, Faiez, Packer, Milton, M, S, J, G, F, JP, George, Jamal, W, Welty, FK, Palmer, Clayton, T, Parhofer, KG, Pedersen, TR, Greenberg, B, Konstam, MA, Lees, KR, Carson, P, Doehner, Miller, A, Haas, Pehrson, Komajda, Anand, I, Teerlink, Rabinstein, Steiner, Kamel, H, Tsivgoulis, Lewis, Freston, Kaplowitz, N, Mann, Petrie, Perrone, Nicholls, Janssens, Bocchi, E, Giannetti, Zhang, Spinar, Seronde, M-F, Boehm, Merkely, Chopra, V, Senni, Taddi, Tsutsui, Choi, D-J, Chuquiure, La Rocca, HPB, Ponikowski, Juanatey, JRG, Squire, Pina, Bernstein, R, Cheung, Green, Kaul, C, Lip, Marx, McCullough, Mehta, Rosenstock, Scirica, Shah, Wanner, Aizenberg, D, Cartasegna, L, Colombo Berra, Colombo, Fernandez Moutin, M (aut